Figure 1. Homozygous Deletion Identified in
Patients from a Consanguineous Italian Family with Autosomal Recessive HSP (A) PCR analysis using primers c1-c2 on HSP family 1; DNA from affected individuals failed to amplify. One affected and two healthy members were not available for the analysis and were withdrawn from the pedigree structure. M, 100 bp DNA molecular weight marker. (B) Southern blot analysis of a control (C) and patient 10 (pt10) DNA probed with the 1.1 kb insert of EST clone 154386. in HSP have yet been identified. The cloning of HSP genes. One of these genes, CMAR (cell adhesion molecule regulator; GenBank accession number S54769), genes is a critical step in understanding the pathogewas originally reported as a 459 bp partially characternetic mechanisms underlying this group of disorders.
ized transcript colinear with genomic DNA and found to Recently, we mapped the locus of a new form of pure be involved in the suppression of tumor invasion (Pullman autosomal recessive HSP to 16q24.3 (SPG7) (De Michele and Bodmer, 1992) . A set of PCR primers, c1 and c2, et al., 1998) . A 9.5 kb deletion involving a previously were designed from the original open reading frame identified partial transcript from 16qter was discovered sequence (Pullman and Bodmer, 1992) and tested on in all affected individuals from a 16q24.3-linked family.
all individuals from our HSP family. As shown in Figure  In addition, two frameshift mutations, both generating 1A, the five affected individuals failed to amplify, while truncated forms of the protein, were found in a French healthy sibs and parents yielded the expected PCR family with a complicated form of HSP and in another product. This result was replicated with a different set Italian family with pure HSP. BLAST analysis revealed of primers, c3 and c4, from the same transcript (data that this gene encodes a novel protein, which we named not shown). Consequently, a homozygous deletion Paraplegin, highly homologous to a subclass of yeast spanning this gene was hypothesized, consistent with mitochondrial metalloproteases. Immunofluorescence the finding of a homozygous haplotype for 16qter markanalysis in transfected COS-7 cells and mitochondrial ers displayed by the affected individuals (De Michele et import in vitro experiments showed a specific mitochonal., 1998) . drial sublocalization. Analysis of muscle biopsy speciSeveral ESTs identical to the reported CMAR semens from two HSP patients carrying Paraplegin mutaquence were found in dbEST, allowing us to build a tions showed the presence of typical signs of OXPHOS 1.1 kb cDNA contig and extending the original 459 bp impairment.
sequence toward the 5Ј end. We selected a few clones, These data demonstrate an abnormality in a nuclearnamely, 154385, 154386 and 31543, which were reseencoded mitochondrial protein and the presence of miquenced either partially or completely (clone 154386), tochondrial OXPHOS defects in HSP, revealing the presconfirming the sequence data reported in dbEST. The ence of an impairment of mitochondrial function in this entire 1.1 kb insert fragment of EST clone 154386 was class of progressive neurodegenerative disorders.
used as a probe on an EcoRI-restricted Southern blot containing DNA from one patient and a control. Figure  Results 1B shows the absence of a 5.6 kb EcoRI band in the patient DNA, thus confirming the presence of a homozy-A 9.5 kb Deletion of Chromosome 16q24.3 in HSP gous deletion. Recently, we described a large consanguineous Italian
To determine the extent of the 16q24.3 deletion in family affected by autosomal recessive HSP (family 1).
HSP patients, an arrayed human genomic PAC library Patients from this family showed typical features of the (Ioannou and de Jong, 1996) was probed with PCR fragpure form of HSP, with age of onset ranging from 25 to ments c1-c2 and c3-c4, spanning from nucleotide 2881 42 and a slow progression of symptoms. A genometo 3016 and from 2524 to 2856 of the cDNA sequence, wide search using a panel of 358 highly polymorphic respectively. One positive clone, 1194G18, was identimicrosatellite markers showed linkage of the disease fied by hybridization screening and confirmed by c1-c2 locus in this family to markers on chromosome 16q24.3 and c3-c4 PCR amplification. Alu-vector-specific PCR in a region spanning approximately 6 cM from D16S3048
primers (see Experimental Procedures) allowed us to to the telomere (De Michele et al., 1998) . This region sequence the ends of the human genomic PAC insert and design two sets of primers at each end of the PAC included several human ESTs as well as some known Figure 2 . Characterization of the Deleted Region (A) Genomic map of the complex 9.5 kb deletion detected in family 1. GRAIL predicted exons are drawn proportionally to their relative probability. Gray boxes denote coding region; open box, 3Ј UTR. Alu repeats are shown as striped boxes. Completely sequenced genomic subclones are indicated by thin lines. At the bottom, black boxes indicate sequences retained in patients carrying the 9.5 kb deletion. (B) PCR amplification of the deletion junction of family 1 using primers c113 and c114 (upper part). The 1.2 kb band is visible only in deleted patients (pt6 and pt10). Lower part, c103-c104 PCR test to confirm the deletion; a single band is present only in the control.
clone. These sets were used to amplify patient DNA in contig of clones gHindB12 and gEco6 and containing the deletion boundaries was sequenced. Alignment of order to study the extent of the deleted region. Positive reactions with both primer sets in patients and controls genomic sequences to the cDNA (see below, Cloning of Paraplegin cDNA) identified five exons of the gene indicate that the deletion was included entirely within the genomic region spanned by the PAC insert (data that are included in this 10.8 kb sequence (Figure 2A ). Grail 2 analysis (Roberts, 1991) of the 10.8 kb genomic not shown). Two plasmid subclones were isolated from two different libraries derived from PAC clones, allowing sequence suggested the presence of these five exons and failed to show other putative exons (Figure 2A ), us to build a 10.8 kb genomic contig (see Experimental Procedures) and several primer sets were designed to indicating that a single gene is contained within this genomic region. investigate the extent of the genomic region deleted in patients (Figure 2A) .
Primers c113 and c114 ( Figure 2A ) were used to amplify the deletion junction in patient DNA. These two The entire 10.8 kb genomic region included in the primers failed to amplify control DNA due to the excessive length (Ͼ 10 kb) of the target sequence, while they amplified a 1.2 kb band in patient DNA ( Figure 2B ). By aligning the sequence of this amplification product to that of the genomic clones spanning the same area, we were able to study the molecular rearrangement underlying the deletion event (Figure 2A ). Control and patient sequences are colinear from the c114 primer to the first deletion breakpoint, which is located after 131 bp. Colinearity continues for 278 bp in an intron sequence between exon -3 and exon -2 and resumes again 932 bp downstream from the end of the last exon for 308 bp. The last breakpoint is encountered 359 bp downstream, where the patient and control sequences are once again identical up to primer c113 (Figure 2A ). Multiple Alu repetitive sequences were detected throughout this genomic fragment (hatched boxes in Figure 2A ). These repeat sequences may have played a role in the generation of this complex rearrangement event.
Cloning of Paraplegin cDNA (SPG7)
A human teratocarcinoma cell line (Andrews et al., 1984) NT2D1 cDNA library was screened using the entire 1.1 kb insert of EST clone 154386 as a probe. Four positive clones were isolated and characterized by sequence analysis ( Figure 3A ). The sequences of clones 5, 12, 13, and 15 were aligned, resulting in a 3080 bp contig sequence, which is entirely covered by clone 5. Clone 13 was found to be rearranged at its 5Ј end, continuing with an Alu sequence. A long open reading frame of 2390 bp was identified, starting at the 5Ј end of clone 5 and ending with a stop codon signal, followed by a 687 bp 3Ј untranslated sequence.
To clone the missing start codon and 5Ј untranslated region (UTR) of Paraplegin mRNA, two different sets of in the canonical Kozak consensus sequence AACATGG (Kozak, 1989) . The sequence surrounding the putative initiation codon was confirmed on the genomic clone region of the SPG7 gene spanning nucleotides 2619-gHindC12 obtained through the screening of a HindIII 3078. This conclusion is based on several lines of eviminilibrary probed with oligonucleotide pr2.
dence. First, a sequence 100% identical to the preThe full-length cDNA sequence of this gene, which viously reported CMAR sequence is found in over 30 was named SPG7, measures 3087 nucleotides with a different SPG7 cDNA clones, including ESTs, identified very short 5Ј UTR, encoding a predicted protein (Parafrom at least 10 different cDNA libraries (data not plegin) of 795 amino acids, and has a 690 bp 3Ј UTR shown). Second, CMAR maps to a single locus in the (Genbank-EMBL accession number Y16610). The size human genome, which is also identified by SPG7 cDNA, of the cDNA sequence is consistent with the data obas shown by Southern analysis using several restriction tained by Northern analyses, which showed an apparenzymes (data not shown). Third, the CMAR probe idenently ubiquitous transcript of approximately 3.2 kb in all tifies the same deletion recognized by SPG7 cDNA in fetal and adult tissues tested ( Figures 3C and 3D ). Two our HSP patients. Fourth, the CMAR probe shows the additional hybridizing transcripts of approximately 2.6 same size transcript as SPG7 on Northern analysis (data and 7.5 kb were detected in heart and pancreas. not shown). Based on our data, the CMAR gene, previously deNo data on the endogenous CMAR protein are found scribed as a 459 bp transcript colinear with genomic DNA (Pullman and Bodmer, 1992) , is part of the 3Ј UTR in the literature. In addition, the CMAR putative protein affected sibs from this family are homozygous for an A insertion at position 2228 of the SPG7 cDNA, while their mother is heterozygous for the same mutation. This insertion creates a frameshift and a stop codon only two amino acids downstream, resulting in a truncated form of Paraplegin that is missing 57 amino acids at the C terminus. 
Paraplegin Is Homologous to Yeast

Mitochondrial Metalloproteases
Affected individuals from family 2 are homozygous for a 2228insA
The nucleotide and predicted amino acid sequences of mutation, while the mother, the obligate carrier, is heterozygous.
Paraplegin were compared with the GenBank and EMBL databases by both BLASTX and TBLASTN algorithms (Altschul et al., 1990) , which yielded similar results. The product is not conserved in primates, based on sehighest similarity was obtained with protein belonging quence analysis of genomic DNA, as major insertions to the AAA family ("AAA" for adenosine triphosphatases and deletions and scattered point mutations were identiassociated with diverse cellular activities [Confalonieri fied in several species . Last, and and Duguet, 1995] ). In addition, homology was also demost importantly, two frequent insertion/deletion polytected with the 5Ј UTR of the murine protein kinase Vik morphisms in the predicted CMAR coding region were (variant in kinase) gene (Kelman et al., 1993) . From our identified in normal individuals (Koyama et al., 1993;  results it is clear that the original Vik cDNA clone re- Durbin et al., 1994) . Both of these polymorphisms result ported by Kelman et al. was chimeric, containing a porin major changes in the CMAR putative protein product.
tion of the murine Paraplegin sequence at its 5Ј end. These observations suggest that the original CMAR This conclusion is also supported by the nonsyntenic cDNA clone may not encode a protein in vivo and that mapping assignments of the Vik and Paraplegin loci. functional data obtained using CMAR cDNA in transfec-
The AAA family consensus sequence is found betion experiments may be due to artifactual translation tween amino acids 344 and 534 of the Paraplegin polyof a peptide encoded by the CMAR sequence.
peptide ( Figure 5A ). Paraplegin showed particularly striking homology to a subclass of the AAA proteins, Identification of Additional Paraplegin Mutations specifically to the yeast metalloproteases AFG3, RCA1, To confirm the involvement of SPG7 in HSP, we searched and to a lesser extent, YME1 (Gué lin et al., 1994; Pajic for mutations in patients from additional HSP families et al., 1994; Schnall et al., 1994; Tzagoloff et al., 1994) and sporadic cases. We tested a total of 14 unrelated ( Figure 5A ), showing 55%, 55%, and 52% amino acid HSP patients for mutations in 10 exons of the SPG7 identity, respectively. These are yeast mitochondrial gene, using partial gene structure information available proteins with both proteolytic and chaperon-like activito us. Patient genomic DNA was amplified using sets ties. Functional domains of these mitochondrial proof primers flanking intron/exon boundaries, and PCR teins, the ATP-binding motif GPPGCGKT and the HEXXH products were used in single strand conformation polymotif typical of a zinc-dependent binding domain, are morphism (SSCP) analysis (see Experimental Procecompletely conserved in Paraplegin ( Figure 5A ). The hodures). The exons tested span approximately 60% of mology between Paraplegin and this mitochondrial subthe coding region.
class of AAA proteins is not limited to these known Two additional mutations were identified. The first functional domains but spans almost the entire protein mutation was found in a recessive family from a small ( Figure 5A ). No vertebrate homolog of these proteins village in southern Italy with two affected brothers (family has been described so far. Figure 5B shows the compar-2), who show typical signs of pure HSP with an age of ison of the hydrophobicity plot of human Paraplegin with onset of 26 years. A 2 bp deletion (784del2) was found those of yeast AFG3 and RCA1. The three hydrophoin the available patient. This mutation causes a framebicity patterns are all very similar. However, the Parashift that abolishes approximately 60% of the protein.
plegin pattern appears to resemble more closely that of The patient is homozygous for this mutation and con-AFG3 rather than RCA1. sanguinity, even though not reported by anamnestic data, is very likely.
The second mutation was found in a French family in Paraplegin Localizes to Mitochondria Computer analysis of Paraplegin leader peptide using which HSP segregates as an autosomal recessive trait (family 3, Figure 4 ). Interestingly, patients from this family the PSORT program (Uberbacher and Mural, 1991) , which allows the prediction of protein localization sites, are affected by a complicated form of HSP with a mean age of onset of 34 years. They showed progressive suggests a mitochondrial localization of Paraplegin protein. MitoProt (Claros and Vincens, 1996) analysis preweakness and spasticity of the lower limbs, decreased perception of sharp stimulation, diminished vibratory dicts a high probability (0.93) of export to mitochondria and a probable cleavage site at position 49. The helical sense, and urinary incontinence, which are typical signs of HSP. In addition, these patients also had optic atrophy wheel pattern (an amphiphilic structure composed of basic residues, mainly arginine, on one side and apolar (3 out of 3 examined), cortical atrophy (1 out of 3 examined), and cerebellar atrophy (2 out of 3 examined). All residues on the opposite side) of the N-terminal region of Paraplegin suggests the presence of typical mitocDNA was transcribed and translated in vitro using T3 RNA polymerase and a reticulocyte lysate preparation chondrial leader sequences (data not shown). This is in the presence of [ 35 S]methionine. A single major band also supported by the biochemical characteristics of the was obtained by in vitro translation of the gene. Radiolaleader peptide, showing a primary sequence enriched beled translation product was incubated with freshly in hydrophobic and basic residues. Among the first 41 prepared mitochondria either fully coupled or previously amino acids, the basic residues are all arginines (high exposed to valinomycin, a powerful uncoupler. When ratios of arginine to lysin are typical of leader peptide) the translation product of human Paraplegin cDNA was (Neupert et al., 1990) and no acidic residues are present.
added to coupled mitochondria, a second shorter band It is worth noting that the submitochondrial localization was obtained in addition to the band corresponding to of Paraplegin onto the inner membrane is consistent the native (precursor) protein. The shorter band correwith the same localization of AFG3 and RCA1 in yeast sponds to the mature protein in which the N-terminal mitochondria.
mitochondrial leader peptide has been cleaved off. ProThe full-length cDNA was assembled using a PCRtein internalization into mitochondria was then assayed cloning strategy, basically by adding the 5Ј sequence by exposure to trypsin. The precursor protein was comobtained from RACE experiments to clone 5 (see Experipletely digested by exposing mitochondria to trypsin, mental Procedures), since all of the isolated cDNA while the mature protein was protected. This result demclones lacked the 5Ј end. The complete coding region onstrates that the mature protein was internalized within of Paraplegin was cloned into a modified pMT21 expresthe inner mitochondrial compartment, which is impersion vector, in frame at its 3Ј end with the c-myc immumeable to trypsin and other proteases. When mitonogenic sequences, in order to produce a Parapleginchondria were preincubated with the OXPHOS uncouc-myc fusion protein.
pler valinomycin, radiolabeled proteins were completely Transfected COS-7 cells were also used to perform digested by trypsin due to inhibition of the energyimmunofluorescence analysis. Figure 6A shows a sidedependent protein transport into mitochondria. by-side comparison of the immunofluorescence pattern
The sizes of the precursor versus mature proteins, of pMTpara c-myc transfected COS-7 cells treated with deduced from the autoradiograph of Figure 6B , indianti-c-myc antibody and of the same cells treated with cates molecular weights of 89 and 81 kDa, respectively. the anti-mtSSB antibody recognizing the mitochondrial These values are consistent with the predicted size of protein SSB (single strand binding protein). In both the Paraplegin native polypeptide (88 kDa) and with a cases, a granular cytoplasmatic pattern with higher denmitochondrial targeting sequence encompassing the sity around the nucleus was observed. This pattern is first 40-50 residues on the amino terminus. Two potenspecific to mitochondrial proteins. No signals were tial cleavage sites, based on the "R-2 rule" (Claros and found in the cytoplasm or in the nucleus in spite of the Vincens, 1996) , are present between amino acids 40-41 strong expression system (i.e., COS-7 cells and pMT and 48-49. vector) used in the experiments. This indicates an exclusive mitochondrial localization.
Mitochondrial OXPHOS Defect in HSP The autoradiography reported in Figure 6B shows the Needle muscle biopsies were taken under informed consent from the left quadriceps of patients 9 and 11, two results of an in vitro mitochondrial import assay. SPG7 to compensate an OXPHOS defect. In support of this view, examination of serial muscle sections showed that the ragged-red, intensely SDH-positive fibers, as well The identification of a 9.5 kb homozygous deletion as other fibers that appeared morphologically normal, including the last 5 exons of the SPG7 gene in a consanhad no reaction to cytochrome c oxidase, the fourth guineous HSP family suggested the involvement of this complex of the mitochondrial respiratory chain (Figure gene in HSP. Definitive evidence of involvement of the 7C). The "COX-deficient fiber" is the histochemical sig-SPG7 gene in HSP came from the identification of point nature of most mitochondrial disorders and thus indimutations in different patients, each resulting in major cates a localized defect of OXPHOS (Dubowitz, 1985) . abnormalities of Paraplegin polypeptide. A total of 14 Electron microscopy examination of a ragged-red fiadditional HSP index cases were tested for mutations ber showed the presence of subsarcolemmal accumulain 10 exons of the SPG7 gene. Two frameshift mutations tion of mitochondria of bizarre shape, with hyperplastic were identified in an Italian and a French family. Interestcristae and paracrystalline inclusions producing typical ingly, patients from the French family are affected by a "parking-lot" structures within numerous organelles (Figcomplicated form that shows, in addition to the typical ure 7D). Less severe changes, i.e., scattered COX-defisigns of HSP, also optic atrophy, cortical atrophy, and cient fibers with no mitochondrial accumulation, were cerebellar atrophy. This multisystem involvement is infound in two muscle biopsies taken from two mildly triguing as it resembles that of mitochondrial disorders. affected individuals, patients 6 and 10 (data not shown).
Considering that only 60% of the coding region was tested, the finding of three independent mutations Discussion among 14 HSP patients tested suggests that Paraplegin defects may be a common cause of HSP. The possibility Mitochondrial biogenesis and function requires the conthat Paraplegin defects may also be involved in autosocerted action of both organelle and nuclear genome mal dominant forms of HSP, due to dominant-negative encoded molecules (Shoffner and Wallace, 1995; Zevi- mutations, must be considered in light of the observaani et al., 1997). We have identified a novel nucleartion that Paraplegin-related molecules in yeast (AFG3 encoded mitochondrial protein, named Paraplegin. This and RCA1) form multimeric complexes (Arlt et al., 1996) . molecule is highly homologous to a mitochondrial subThese data demonstrate a mitochondrial protein declass of yeast ATPases. Members of this subclass are fect in HSP. Among several hypotheses made on the the ATP-dependent metallopeptidases AFG3, RCA1, pathogenetic mechanisms underlying HSP, a mitochonand YME1 (also known as Yta10p, Yta12p, and Yta11p, drial involvement has never been postulated before. Horespectively), originally identified by genomic sequencmology between Paraplegin and yeast mitochondrial ing and complementation studies in yeast (Gué lin et al., proteins and localization of Paraplegin to mitochondria 1994; Pajic et al., 1994; Schnall et al., 1994 ; Tzagoloff prompted us to analyze the patients' mitochondria. . Paraplegin represents the first vertebrate finding of morphological and functional abnormalities homolog of this class of proteins described so far.
typical of mitochondrial OXPHOS defects in muscle In yeast, AFG3 and RCA1 form a membrane-embedbiopsy specimens of patients from the family carrying ded complex that has both a protease activity, needed a deletion of the SPG7 gene provides an important clue for ATP-dependent degradation of mitochondrial transto the pathogenesis of HSP. Interestingly, in this family lation products, and a chaperon-like function, mediating the severity of the cellular phenotype appears to correassembly of membrane-associated ATP synthase (Arlt late with the severity of the symptoms, as the two paet al., 1996) . The correct folding and assembly of these tients with the most compromised neurological phenoproteins is needed for functional respiratory chain protype also showed a higher percentage of pathological cesses (Paul and Tzagoloff, 1995) . Yeast strains carrying muscle fibers. mutations in either AFG3, RCA, or YME1 genes are deAs in other mitochondrial diseases, the clinical specficient in the assembly of functional respiratory and trum of Paraplegin defects is variable, with some paATPase complexes Paul and Tzago- tients having pure forms with exclusive involvements of loff, 1995; Rep et al., 1996b) . specific axonal populations, while others have multisysWe demonstrated that Paraplegin localizes to mitotemic forms (Shoffner and Wallace, 1995) . At this point, chondria. This is based on several lines of evidence.
we cannot explain why a defect in an apparently ubiquiFirst, computer analysis of Paraplegin sequence pretous protein required for mitochondrial function affects dicts the presence of a mitochondrial targeting peptide primarily specific axonal populations such as the cortiin the amino terminus of the protein (data not shown).
cospinal tracts and the dorsal columns. These are the Second, immunofluorescence studies on transfected longest axons in the human body and may be more COS-7 cells showed a fine granular pattern in the cytosensitive to an impairment of the mitochondrial protein plasm, more intense in the perinuclear region, typical of degradation machinery. mitochondrial proteins such as SSB, which colocalizes Another autosomal recessive neurodegenerative diswith Paraplegin ( Figure 6A ). No signal was observed order due to mutations in a mitochondrial protein is in other cell structures, indicating that the protein was Friedreich ataxia (FA). This disease, besides presenting targeted only to mitochondria. Last, energy-dependent many clinical analogies with HSP, is due to a defect in mitochondrial targeting and cleavage were demonFrataxin, a mitochondrial protein involved in iron homeostrated by experiments of mitochondrial import and stasis and respiratory function (Gray and Johnson, 1997; trypsin-protection assays in vitro. Together, sequence Rotig et al., 1997) . A defect of iron-dependent mitochonidentity values ( Figure 5A) , comparison of the hydrophodrial enzymes, including some respiratory complexes, bicity plots ( Figure 5B) , and subcellular localization studhas recently been demonstrated in two FA patients ies ( Figures 6A and 6B) suggest that Paraplegin function in human is similar to that of AFG3 in yeast. (Rotig et al., 1997 HSP may be the first example of this class of disorders.
Southern and Northern Blots
In yeast, many of the factors involved in the biogenesis Southern blot analysis was performed by loading 7 g of genomic of mitochondrial respiratory chain are known to cooper-DNA using standard protocol (Sambrook et al., 1989) . Fetal tissues ate, having partially overlapping roles. For instance, inNorthern blot, containing 2 g per lane of polyA ϩ RNA, was puractivation of either AFG3 or RCA1 genes can be complechased from Clontech (Palo Alto, CA) and hybridized using standard mented by overexpression of the LON gene (Rep et al., protocol (Sambrook et al., 1989). 1996a). In the case of HSP, it is possible that other
Cloning and Sequencing the Deletion Region mitochondrial factors with a similar function can com-
The human arrayed genomic library RPCI-5 was previously reported pensate Paraplegin defects, at least in part, thus reduc- (Ioannou and de Jong, 1996) . To perform a fine characterization of ing the severity of symptoms. partially overlapping gEco6 (see Figure 2A ). The deletion region was (Sambrook et al., 1989) . 5Ј RACE-PCR may be a common mechanism in HSPs, and it is tempt- (Frohman et al., 1988) was performed on human fetal brain and ing to speculate that it may also be involved in other networks, should be considered candidate genes for this class of disorders.
Mutation Detection
The 2 bp deletion mutation, 784del2, is located on exon 6 of the The data presented in this paper may also have clinical gies for HSP. pMTpara c-myc Expression Construct Clone 5 was replaced at its 5Ј end by the PCR fragment obtained Experimental Procedures by primer muATG2, GCGAATTCAGGCCAACATGGCCGTGCTGCTG CTGCTG, introducing an EcoRI site upstream from the endogenous Oligonucleotide Primers ATG start codon and c34Bam, TGGGATCCTGTCCTTGGCC, and PCR reactions were performed in a final volume of 20 l in standard restricted by EcoRI and HindIII (naturally occurring at position 688). conditions and using the following primers (as indicated in the ReThe 3Ј end of modified clone 5, named BS-Paraplegin, was replaced sults section): c1, TAGACAGTCGTTCCCAGTGT; c2, AAACCAAGGC by the BstEII (position 1974)-XhoI restricted PCR fragment obtained ATCCCCAACA; c3, GACTTCTGAGATCTGTTGATTG; c4, TGGAGAT with c20, GCAATGAGGCTGCGCTGCA, and mu-stopX, ctccctcgagc AGGACAATCGGC; c101, TGTGAGACACGTTTGCAGCG; c106, AAT CTTGGGCCAAGTCGGCTCTTC, deleting the natural stop codon and GTTCTAAATGGATGGGAGG; c109, GATCCAGAAAGTGATGGGGA; introducing an XhoI site. A 2400 bp EcoRI-XhoI fragment was cloned c111, GCCTCCTGCTTACTTTCCCTCT; c113, GGTACCCGACTGAA into a modified pMT21 vector containing the c-myc epitope (a gift AATGTC; c114, GGGAGAGGGAAAGTAAGCAG; pr2, GAGGCCTGCT of M. Tessier-Lavigne), thus obtaining pMTpara c-myc . GGCCATGTAC.
COS-7 Transfection and Western Blot
Transient transfection of pMTpara c-myc into COS-7 cells was perCloning the PAC Insert Ends To clone one PAC insert extremety, a vector-specific primer (PAC3, formed with lipofectamine (GIBCO BRL) according to the manufacturer's instructions. Undiluted supernatant of monoclonal antibody GGCACCTGTCCTACGAGTTG; flanking the BamHI cloning site of pCYPAC2) and the Alu repeat-specific primer (AluPrimer, AGGAGTG anti-c-myc 9E10 (Evan et al., 1985) was used as primary antibody.
Immunocytochemistry
Dü rr, A., Brice, A., Serdaru, M., Rancurel, G., Derouesné , C., LyonCaen, O., Agid, Y., and Fontaine, B. (1994) . The phenotype of "pure" Transfected cells were washed in PBS, fixed in 4% paraformaldeautosomal dominant spastic paraplegia. Neurology 44, 1274-1277. heide/PBS for 30 min, blocked for 60 min in PBS, 10% porcine serum, and 0.2% Triton X-100, incubated 120 min with primary antiEvan, G.I., Lewis, G.K., Ramsay, G., and Bishop, J.M. (1985) . Isolabodies, anti c-myc 9E10 and anti-mtSSB, diluted 1:200 (Tiranti et tion of monoclonal antibodies specific for human c-myc proto-oncoal., 1993) in PBS/1% porcine serum/0.1% Triton X-100. Cultures gene product. Mol. Cell. Biol. 5, 3610-3616. were then washed twice with PBS and incubated with 1:200 FITCFilla, A., De Michele, G., Marconi, R., Bucci, L., Carillo, C., Castellano, conjugated anti-mouse secondary antibody (for anti-c-myc) and
A.E., Iorio, L., Kniahynicki, C., Rossi, F., and Campanella, G. (1992 tion of full-length cDNAs from rare transcripts: amplification using Ci/mmole), as previously described by Tiranti et al. (1997) .
a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85, 8998-9002.
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